Danish allergy immunotherapy specialist ALK has announced that the UK’s Medicines and Healthcare Products Regulatory Agency ...

Oncologic Drugs Advisory Committee has voted against two proposed combination regimens containing GSK’s Blenrep (belantamab ...

In what is not exactly a win-win situation for the Indian generic firms, a recent federal court ruling in Delaware, USA, has ...

US healthcare giant Johnson & Johnson announced that the prestigious medical journal The Lancet has published positive ...

US biotech TRIO Pharmaceuticals has announced the appointment of Patrick Doyle as chief executive (CEO effective immediately.

Scottish biotech Trogenix has announced two senior appointments as the company advances its pipeline towards the clinic.

The market for selective estrogen receptor modulators, or SERMs, is poised for considerable growth over the next decade, ...

The European Medicines Agency has called for updated rules and processes to reflect growing use of artificial intelligence in ...

US precision immune-oncology firm I-Mab has entered into a definitive agreement to acquire 100% ownership of Bridge Health ...

The Institute for Clinical and Economic Review (ICER) has cast doubt on the value of a new spinal muscular atrophy treatment ...

Japanese drug major Astellas Pharma has signed a memorandum of understanding with the Korea Institute of Startup and ...

Behind the Numbers 2026 report, outlining the primary inflators and deflators of healthcare costs across the industry. It ...